Continuing to explore strategic alternatives focusing on maximizing stockholder value Presented results from Phase 1 clinical trial of ATH-1105 in healthy volunteers demonstrating a favorable safety and tolerability profile as well as dose proportional pharmacokinetics and CNS penetration, supporting continued clinical development BOTHELL, Wash., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore ...

REDWOOD CITY, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today reported financial results and provided a business update for the three months ended September 30, 2025. “We remain on track to report topline results from the Phase 3 sunRIZE trial in congenital hyperinsulinism in December,” said Nevan Charles Elam, Chief Executive Officer and Founder of Rezol ...

— Revenue Increased 5.0% — — Repurchased $400 Million of Shares — KANSAS CITY, Mo., Nov. 06, 2025 (GLOBE NEWSWIRE) -- H&R Block, Inc. (NYSE: HRB) (the "Company") today released financial results1 for its fiscal 2026 first quarter ended September 30, 2025. "Fiscal 2026 is off to a strong start, not only in the financial results we are reporting but also in the plans we are preparing to execute in the coming quarters," said Jeff Jones, president and chief executive officer. "Our team is excited to build on ...

CANTON, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Results Summary: Net product revenue of $150.5 million for the third quarter of 2025, an increase of $35.3 million co ...

ORLANDO, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- PureCycle Technologies, Inc. (Nasdaq: PCT), a U.S.-based company revolutionizing plastic recycling, announced today a corporate update for the third quarter ending September 30, 2025. Management Commentary PureCycle CEO Dustin Olson said, “The third quarter was one of continued growth for the Company. The Ironton Facility produced a record 7.2 million pounds of pellets, which is nearly equal to the amount produced in the first half of 2025.” Olson continued, ...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Scott Lendrum, CEO of Giga Metals Corp. (“Giga Metals” or the “Company”) (TSX-V: GIGA; OTCQB: GIGGF; FSE: BRR2) is pleased to announce that Giga has completed the private placement previously announced on October 15, 2025. The Company closed 3,904,109 Units at $0.11 per Non-Flow-Through Unit for gross proceeds of $429,451 and 8,637,693 Units at $0.13 per Flow-Through Un ...

LONG BEACH, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2025 (“Q3 2025”). “Our third-quarter results reflect disciplined execution and the continued strengthening of BeautyHealth’s foundation,” said BeautyHealth President and CEO, Pedro Malha. "Revenue of $70.7 million and Adjusted EBITDA of $8.9 million exceeded the top end ...

Strengthened balance sheet with private placement of up to $100 million to advance CMP-002, a first-in-class treatment for SYNGAP1-related disorders Initiated Good Laboratory Practice (GLP) toxicology studies for CMP-002 in support of a planned clinical trial application for a Phase 1/2 clinical trial expected to initiate as early as 2H 2026 Completed analysis from multiple ascending dose (MAD) portion of the CMP-001 Phase 1 clinical trial demonstrating favorable safety and pharmacokinetics in line with ex ...

公司活动 - 公司管理层将于2025年11月11日在佛罗里达州迈阿密的JW Marriott Miami Turnberry举行的Piper Sandler金融服务会议上进行演讲 [1] - 管理层将在会议当天与投资者进行交流 [2] - 投资者可在公司官网投资者关系栏目下载演示文稿的PDF副本 [2] 公司业务概览 - 公司是一家专业金融公司，业务包括在多个消费和商业行业发起和服务贷款，以及通过金融科技战略合作伙伴提供贷款产品和服务 [1] - 公司及其子公司主要业务为发起和服务不断增长的消费贷款及夹层贷款组合 [3] - 关键服务行业包括休闲娱乐（可拖挂式房车和船舶）和家居装修（屋顶更换、游泳池和窗户） [3] - 公司总部位于纽约州纽约市，其最大子公司Medallion Bank总部位于犹他州盐湖城 [3]

SHAKOPEE, Minn., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Canterbury Park Holding Corporation (“Canterbury” or the “Company”) (Nasdaq: CPHC) today reported financial results for the three and nine months ended September 30, 2025. ($ in thousands, except per share data and percentages) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 Change 2025 <td colspan="2" style="border-top: solid black 1pt ; padding-left: 0 ; border-bottom: solid black 1pt ; text-align: center ; vertical-align: m ...